As of 2026-09-16, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 16.3x | 15.7x |
| Forward P/E multiples | 16.0x - 19.2x | 17.8x |
| Fair Price | (19.48) - (19.86) | (20.47) |
| Upside | -184.7% - -186.3% | -188.9% |
| Date | EV/EBITDA |